Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease

Current cerebrospinal fluid (CSF) tests for sporadic Creutzfeldt–Jakob disease (sCJD) are based on the detection of surrogate markers of neuronal damage such as CSF 14‐3‐3, which are not specific for sCJD. A number of prion protein conversion assays have been developed, including real time quaking‐induced conversion (RT‐QuIC). The objective of this study is to investigate whether CSF RT‐QuIC analysis could be used as a diagnostic test in sCJD.

[1]  B. Caughey,et al.  Prion Disease Blood Test Using Immunoprecipitation and Improved Quaking-Induced Conversion , 2011, mBio.

[2]  J. Castilla,et al.  Presymptomatic Detection of Prions in Blood , 2006, Science.

[3]  A. Green,et al.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[5]  B. Crain,et al.  Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein , 2010, Annals of neurology.

[6]  B. Caughey,et al.  Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. , 2009, Protein engineering, design & selection : PEDS.

[7]  G. J. Raymond,et al.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state , 1991, Journal of virology.

[8]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[9]  B. Caughey,et al.  Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking , 2008, Nature Methods.

[10]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[11]  N. Xiang,et al.  Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007 , 2008, BMC public health.

[12]  Ritchie,et al.  Clinical and Neuropathological Investigations in Creutzfeldt-Jakob Disease , 2022 .

[13]  Steven J Collins,et al.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.

[14]  O. Simell,et al.  The normal population distribution of PRNP codon 129 polymorphism , 2003, Acta neurologica Scandinavica.

[15]  C. McLean,et al.  Creutzfeldt-Jakob disease: diagnostic utility of 14–3–3 protein immunodetection in cerebrospinal fluid , 2000, Journal of Clinical Neuroscience.

[16]  Brent Race,et al.  Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.

[17]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[18]  K. Eguchi,et al.  14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan , 2006, Cellular and Molecular Neurobiology.

[19]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[20]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.